Reports Q4 revenue $21.7M vs. $17.7M last year. Performance in the quarter was driven by 45% year-over-year analysis growth in North America and 32% in Asia Pacific. “We finished 2025 strong, with Q4 revenue growing 22% and full-year revenue increasing 19% year-over-year, as our growth momentum continues to accelerate,” said CEO Jurgi Camblong.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOPH:
- SOPHiA GENETICS Posts Strong 2025 Growth and Reaffirms 2026 Outlook
- SOPH Upcoming Earnings Report: What to Expect?
- Sophia Genetics signs two major U.S. healthcare systems
- SOPHiA GENETICS Expands Perceptive Credit Facility With New $25 Million Term Loan Capacity and Additional Warrants
- Sophia Genetics price target raised to $7 from $6 at Guggenheim